Table 1.
Histology, stage and age of included vs. excluded patients
| EOC included N = 198 | EOC excluded due to insufficient tumor tissue N = 24 | P-Value | |
|---|---|---|---|
| Histology | 0.189 | ||
| Serous adenocarcinoma, n (%) | 163(82.3 %) | 17(70.8 %) | |
| Mucinous adenocarcinoma, n (%) | 11(5.6 %) | 1(4.2 %) | |
| Endometrioid adenocarcinoma, n (%) | 15(7.6 %) | 3(12.5 %) | |
| Clear Cell carcinoma, n (%) | 9(4.5 %) | 3(12.5 %) | |
| Tumor stage | 0.494 | ||
| Stage I, n (%) | 31(15.7 %) | 6(25.0) | |
| Stage II, n (%) | 21(10.6 %) | 1(4.2 %) | |
| Stage III, n (%) | 120(60.1 %) | 13(54.2 %) | |
| Stage IV, n (%) | 26(13.1 %) | 4(16.7 %) | |
| Age, median (range) | 64(58) | 62(53) | 0.414 |
Abbreviations: EOC epithelial ovarian cancer, Tumor stage the international federation of gynecology and obstetrics (FIGO) stage